# Jas Diagnostics, Inc.

- Location (FDA's records): Miami, FL
- FDA decisions: 20 (2000–2014): 20 510(k) clearances
- Product codes: CIG (2), LBS (1), CIX (1), KHS (1), CJY (1), CIT (1), KNK (1), CFR (1), JJE (1), LCP (1), CEO (1), JGJ (1)
- Predicates its devices cite: 1 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 3 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Olympus America, Inc.: 1 (https://510kreport.com/company/olympus-america)

## Firms that cite its devices most
- Drew Scientific, Ltd.: 2 (https://510kreport.com/company/drew-scientific)

## Its most-cited devices
- K011900: Glucose (Hexokinase) (2001), cited by 1
- K003247: Creatinine (2000), cited by 1

## Recent decisions
- K130915: XL-200 Clinical Chemistry Analyzer, Jas Glucose Reagent, Ise Reagent Pack (May 15, 2014)
- K080623: Cholesterol Oxidase Jase, and Glycerol Inase Triglycerides, Model NA (Nov 17, 2008)
- K080618: Direct HBA1C, Fructosamine, Glucose Oxidase Liquid (May 23, 2008)
- K022519: LDL Cholesterol (Automated) (Sep 30, 2002)
- K021671: Jas HDL Cholesterol (Automated) Reagent (Jul 19, 2002)
- K020454: Chemistry Calibrator (Apr 8, 2002)
- K020282: Jas Amylase Liquid Reagent (Feb 28, 2002)
- K013912: Creatine Kinase (CK-Nac) (Jan 18, 2002)

Source page: https://510kreport.com/company/jas-diagnostics